JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 3, 2008; DOI: 10.1124/jpet.108.146589

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Vemula, S.
Right arrow Articles by Abbruscato, T. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vemula, S.
Right arrow Articles by Abbruscato, T. J.


Received for publication September 24, 2008.
Revised October 30, 2008.
Accepted for publication October 30, 2008.

A functional role for sodium dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation

Sharanya Vemula 1, Karen Roder 1, Tianzhi Yang 1, G. Jayarama Bhat 1, Thomas J. Thekkumkara 1, Thomas J. Abbruscato 2*

1 Texas Tech University Health Sciences Center 2 Texas Tech University Health Science Center

* Address correspondence to: E-mail: thomas.abbruscato{at}ttuhsc.edu

Abstract

In the current study we determined the functional significance of sodium dependent/independent glucose transporters at the neurovasculature during oxygen glucose deprivation (OGD). Confluent brain endothelial cells cocultured with astrocytes were exposed to varying degrees of in vitro stroke conditions. Glucose transporter 1 (GLUT1) and sodium glucose cotransporter (SGLT) activity were investigated by luminal membrane uptake and transport studies using [3H] D-glucose and also by [14C] alpha methyl D-glucopyranoside (AMG), a specific, nonmetabolized substrate of SGLT. In vivo middle cerebral artery occlusion (MCAO) experiments were tested to determine if blood-brain barrier (BBB) SGLT activity was induced during ischemia. Increases in luminal D-glucose and AMG uptake and transport were observed with in vitro stroke conditions. Specific inhibitor experiments suggest a combined role for both SGLT and GLUT1 at the BBB during OGD. A time dependent increase in the uptake of AMG was also seen in mice exposed to permanent focal ischemia and this increase was sensitive to SGLT inhibitor, phlorizin. Infarct and edema ratio during ischemia were significantly decreased by the inhibition of this transporter. These results show that both GLUT1 and SGLT play a role at the BBB in the blood-to-brain transport of glucose during ischemic conditions and inhibition of SGLT during stroke has the potential to improve stroke outcome. Pharmacological modulation of this novel BBB transporter could prove to be a brain vascular target in stroke.


Key words: Blood-brain barrier, Brain Edema, Focal Ischemia, Glucose transport, Sodium Glucose Cotransporter, Stroke





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.